Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9AR24
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003723 | RNA binding | 4 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.562 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.748 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.672 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.649 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.756 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.723 |
DEG_APCC_DBOX_1 | 253 | 261 | PF00400 | 0.490 |
DEG_APCC_DBOX_1 | 61 | 69 | PF00400 | 0.438 |
DOC_CYCLIN_yClb3_PxF_3 | 214 | 220 | PF00134 | 0.537 |
DOC_MAPK_MEF2A_6 | 254 | 263 | PF00069 | 0.502 |
DOC_MAPK_MEF2A_6 | 294 | 303 | PF00069 | 0.455 |
DOC_PP2B_LxvP_1 | 182 | 185 | PF13499 | 0.537 |
DOC_PP4_FxxP_1 | 188 | 191 | PF00568 | 0.638 |
DOC_PP4_FxxP_1 | 195 | 198 | PF00568 | 0.574 |
DOC_PP4_FxxP_1 | 263 | 266 | PF00568 | 0.530 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.434 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.708 |
DOC_USP7_UBL2_3 | 38 | 42 | PF12436 | 0.486 |
DOC_WW_Pin1_4 | 241 | 246 | PF00397 | 0.371 |
DOC_WW_Pin1_4 | 78 | 83 | PF00397 | 0.636 |
LIG_14-3-3_CanoR_1 | 12 | 19 | PF00244 | 0.476 |
LIG_BIR_III_2 | 66 | 70 | PF00653 | 0.520 |
LIG_EVH1_2 | 184 | 188 | PF00568 | 0.529 |
LIG_EVH1_2 | 191 | 195 | PF00568 | 0.498 |
LIG_FHA_1 | 290 | 296 | PF00498 | 0.522 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.440 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.630 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.463 |
LIG_FHA_2 | 49 | 55 | PF00498 | 0.459 |
LIG_LIR_Apic_2 | 187 | 191 | PF02991 | 0.504 |
LIG_LIR_Apic_2 | 194 | 198 | PF02991 | 0.486 |
LIG_LIR_Apic_2 | 209 | 214 | PF02991 | 0.517 |
LIG_LIR_Gen_1 | 114 | 121 | PF02991 | 0.614 |
LIG_LIR_Gen_1 | 13 | 23 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 114 | 118 | PF02991 | 0.612 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 241 | 246 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.361 |
LIG_MYND_1 | 215 | 219 | PF01753 | 0.541 |
LIG_PTB_Apo_2 | 226 | 233 | PF02174 | 0.465 |
LIG_SH2_CRK | 211 | 215 | PF00017 | 0.427 |
LIG_SH2_STAT3 | 121 | 124 | PF00017 | 0.610 |
LIG_SH3_3 | 212 | 218 | PF00018 | 0.508 |
LIG_SH3_3 | 290 | 296 | PF00018 | 0.387 |
LIG_SUMO_SIM_anti_2 | 256 | 261 | PF11976 | 0.502 |
LIG_SUMO_SIM_par_1 | 283 | 290 | PF11976 | 0.525 |
LIG_TRAF2_1 | 82 | 85 | PF00917 | 0.720 |
LIG_WRC_WIRS_1 | 32 | 37 | PF05994 | 0.610 |
LIG_WRC_WIRS_1 | 49 | 54 | PF05994 | 0.292 |
MOD_CDK_SPxxK_3 | 241 | 248 | PF00069 | 0.385 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.483 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.507 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.669 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.560 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.582 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.555 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.648 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.406 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.624 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.619 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.496 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.673 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.772 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.572 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.475 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.597 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.700 |
MOD_LATS_1 | 130 | 136 | PF00433 | 0.551 |
MOD_N-GLC_1 | 161 | 166 | PF02516 | 0.738 |
MOD_N-GLC_1 | 276 | 281 | PF02516 | 0.302 |
MOD_NEK2_1 | 232 | 237 | PF00069 | 0.530 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.523 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.449 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.440 |
MOD_PIKK_1 | 89 | 95 | PF00454 | 0.552 |
MOD_PKA_1 | 132 | 138 | PF00069 | 0.603 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.474 |
MOD_PKA_2 | 126 | 132 | PF00069 | 0.582 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.598 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.502 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.444 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.445 |
MOD_ProDKin_1 | 241 | 247 | PF00069 | 0.371 |
MOD_ProDKin_1 | 78 | 84 | PF00069 | 0.641 |
MOD_SUMO_rev_2 | 106 | 111 | PF00179 | 0.570 |
TRG_ER_diArg_1 | 148 | 151 | PF00400 | 0.658 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.737 |
TRG_NLS_MonoExtN_4 | 96 | 103 | PF00514 | 0.673 |
TRG_Pf-PMV_PEXEL_1 | 237 | 241 | PF00026 | 0.267 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P0T6 | Trypanosomatidae | 35% | 100% |
A0A3Q8IAN2 | Leishmania donovani | 85% | 100% |
A0A3R7MFN4 | Trypanosoma rangeli | 35% | 100% |
A4H8Z8 | Leishmania braziliensis | 74% | 100% |
A4HXC9 | Leishmania infantum | 86% | 100% |
D0A4S0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
Q4QED9 | Leishmania major | 84% | 98% |
V5AZY6 | Trypanosoma cruzi | 36% | 100% |